The Technology team advised Gabbi on its $4.4 million Series Seed financing round to help tackle its mission of ensuring breast cancer is detected at the earliest possible stages when it is a treatable, survivable disease.
The round was led by Bread and Butter Ventures, with participation from Female Founders Fund, Hambrecht Ducera Healthcare Growth Ventures, Phoenix Rising, Claridge Ventures Advisors VC, Coyote Ventures, Gaingels, and angel investors including David Kidder, Sarah Jones Simmer and Naseem Sayani.
Gabbi is a revolutionary breast cancer risk assessment and early detection solution delivering immediate, accurate results for women of all ages and all ethnicities. Using artificial intelligence Gabbi predicts a woman’s risk of breast cancer, provides her with a personalized plan, and navigates her to an early detection.
The Goodwin team was led by Emma Mann-Meginniss, Simone Otenaike, Morgan Monroe, Ari Ghavami and JB Schiller, with invaluable assistance from Dondi Dancy and Artimus Cunningham.
For more details, read the press release and article in The Wall Street Journal.